Glioblastoma survival [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.
====== Glioblastoma survival ======

{{rss>https://pubmed.ncbi.nlm.nih.gov/rss/search/10QQLaXyfCAAaEHvLh06_RuZL4p5RenhBGWAqZDJGOb8Db6QHV/?limit=15&utm_campaign=pubmed-2&fc=20230711113955}}
----

----


Advances in [[glioblastoma diagnosis]] and [[glioblastoma surgery]] mean that [[radical]] [[resection]]s can be performed even in [[eloquent]] [[brain]] [[area]]s. However, patients not indicated for resection will experience a major reduction in [[life expectancy]]. Patients who underwent [[stereotactic biopsy]] and received some form of oncological treatment experienced slightly increased [[overall survival]] relative to patients with a natural disease [[course]]. Patients with favorable clinical factors reacted better to treatment
((Halaj M, Kalita O, Tuckova L, Hrabalek L, Dolezel M, Vrbkova J. [[Life expectancy]] in [[glioblastoma]] patients who had undergone [[stereotactic biopsy]]: a retrospective single-center study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023 Jul 10. doi: 10.5507/bp.2023.030. Epub ahead of print. PMID: 37431620.))

===== Overall survival =====

[[Glioblastoma overall survival]].


----


[[Glioblastoma]] patients who were readmitted within 30 days had significantly shorter survival than nonreadmitted patients. Future studies that attempt to decrease readmissions and evaluate the impact of reducing readmissions on patient outcomes are needed
((Nuño M, Ly D, Ortega A, Sarmiento JM, Mukherjee D, Black KL, Patil CG. Does
30-Day Readmission Affect Long-term Outcome Among Glioblastoma Patients?
Neurosurgery. 2014 Feb;74(2):196-205. doi: 10.1227/NEU.0000000000000243. PubMed
PMID: 24176955.)).

Despite advances in treatment, the median patient survival is 12 to 15 months
((DeAngelis LM. Brain tumors. N Engl J Med. 2001;344(2):114–123. )).

===== Glioblastoma progression =====

[[Glioblastoma progression]].